These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 6480157
1. Biologic and biochemical differences between in vitro and in vivo passaged Friend erythroleukemia cells. II. Changes in cell surface glycoproteins associated with a highly malignant phenotype. Amici C, Ferrantini M, Benedetto A, Belardelli F, Gresser I. Int J Cancer; 1984 Sep 15; 34(3):397-402. PubMed ID: 6480157 [Abstract] [Full Text] [Related]
2. Biologic and biochemical differences between in vitro and in vivo passaged Friend erythroleukemia cells. I. Tumorigenicity and capacity to metastasize. Belardelli F, Ferrantini M, Maury C, Santurbano L, Gresser I. Int J Cancer; 1984 Sep 15; 34(3):389-95. PubMed ID: 6207117 [Abstract] [Full Text] [Related]
3. Hyposialylation of high-molecular-weight membrane glycoproteins parallels the loss of metastatic potential in wheat-germ agglutinin-resistant Friend leukemia cells. Benedetto A, Elia G, Sala A, Belardelli F. Int J Cancer; 1989 Jan 15; 43(1):126-33. PubMed ID: 2910824 [Abstract] [Full Text] [Related]
4. Wheat germ agglutinin-binding protein changes in highly malignant Friend leukemia cells metastasizing to the liver. Elia G, Ferrantini M, Belardelli F, Proietti E, Gresser I, Amici C, Benedetto A. Clin Exp Metastasis; 1988 Jan 15; 6(5):347-62. PubMed ID: 3163957 [Abstract] [Full Text] [Related]
5. Friend murine leukemia virus and spleen focus-forming virus expression in highly malignant interferon-sensitive and interferon-resistant Friend leukemia cells. Oppi C, Fiorucci G, Ferrantini M, Battistini A, Belardelli F. Virology; 1986 Apr 30; 150(2):390-401. PubMed ID: 2421480 [Abstract] [Full Text] [Related]
6. Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with the in vivo behaviour of tumor cells. Ferrantini M, Pulciani S, Proietti E, Lespinats G, Anastasi A, Ciolli V, Rizza P, Belardelli F. Clin Exp Metastasis; 1989 Apr 30; 7(6):609-25. PubMed ID: 2476272 [Abstract] [Full Text] [Related]
7. Growth properties, differentiation capacity and oncogene expression in metastatic and nonmetastatic Friend leukemia cell variants. Sala A, Benedetto A, Elia G, Pulciani S, Ciotta C, Parlanti E, Santodonato L, Belardelli F. Invasion Metastasis; 1991 Apr 30; 11(4):192-203. PubMed ID: 1765432 [Abstract] [Full Text] [Related]
8. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells. Ferrantini M, Proietti E, Santodonato L, Gabriele L, Peretti M, Plavec I, Meyer F, Kaido T, Gresser I, Belardelli F. Cancer Res; 1993 Mar 01; 53(5):1107-12. PubMed ID: 8439955 [Abstract] [Full Text] [Related]
9. Natural resistance in mice against Friend leukemia cells. I. Studies with in vitro passaged interferon-sensitive and interferon-resistant cell clones. Iorio A, Neri M, Federico M, Rossi GB, Bonmassar E. Cell Immunol; 1986 Mar 01; 98(1):230-7. PubMed ID: 2427224 [Abstract] [Full Text] [Related]
10. Cell surface sialylation of glycoproteins and glycosphingolipids in cultured metastatic variant RNA-virus transformed non-producer BALB/c 3T3 cell lines. Yogeeswaran G, Sebastian H, Stein BS. Int J Cancer; 1979 Aug 01; 24(2):193-202. PubMed ID: 385511 [Abstract] [Full Text] [Related]
11. Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases. Kaido T, Gresser I, Maury C, Maunoury MT, Vignaux F, Belardelli F. Int J Cancer; 1993 May 28; 54(3):475-81. PubMed ID: 8509222 [Abstract] [Full Text] [Related]
12. Identification of exposed surface glycoproteins of four human bladder carcinoma cell lines. Steele JG, Rowlatt C, Sandall JK, Franks LM. Biochim Biophys Acta; 1983 Jul 13; 732(1):219-28. PubMed ID: 6871191 [Abstract] [Full Text] [Related]
13. Two-dimensional electrophoresis of membrane proteins from normal and transformed cells. Litin BS, Grimes WJ. Cancer Res; 1979 Jul 13; 39(7 Pt 1):2595-603. PubMed ID: 445461 [Abstract] [Full Text] [Related]
15. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells. Gresser I, Maury C, Woodrow D, Moss J, Grütter MG, Vignaux F, Belardelli F, Maunoury MT. Int J Cancer; 1988 Jan 15; 41(1):135-42. PubMed ID: 3422071 [Abstract] [Full Text] [Related]
16. Glycoconjugates of murine tumor lines with different metastatic capacities. I. Differences in fucose utilization and in glycoprotein patterns. Schwartz R, Schirrmacher V, Mühlradt PF. Int J Cancer; 1984 Apr 15; 33(4):503-9. PubMed ID: 6706434 [Abstract] [Full Text] [Related]
17. Surface membrane glycoproteins of cultured human pancreatic cancer cells. Kim YS, Tsao D, Hicks J, McIntyre LJ. Cancer; 1981 Mar 15; 47(6 Suppl):1590-6. PubMed ID: 7272911 [Abstract] [Full Text] [Related]
18. Effect of mouse interferon alpha/beta on the expression of H-2 (class I) antigens and on the levels of 2'-5' oligoadenylate synthetase activity in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice. Locardi C, Belardelli F, Federico M, Romeo G, Affabris E, Gresser I. J Biol Regul Homeost Agents; 1987 Mar 15; 1(4):189-94. PubMed ID: 3332546 [Abstract] [Full Text] [Related]
19. Characterization of surface glycoproteins of mouse lymphoid cells. Gahmberg CG, Häyry P, Andersson LC. J Cell Biol; 1976 Mar 15; 68(3):642-53. PubMed ID: 192730 [Abstract] [Full Text] [Related]
20. Importance of interferon alpha in the resistance of allogeneic C57B1/6 mice to the multiplication of Friend erythroleukemia cells in the liver. Gresser I, Maury C, Bandu MT, Belardelli F. Int J Cancer; 1990 Feb 15; 45(2):364-71. PubMed ID: 2406205 [Abstract] [Full Text] [Related] Page: [Next] [New Search]